Vaginal cancer surgery

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]

Vaginal cancer Microchapters


Patient Information


Historical Perspective




Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination


Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Vaginal cancer surgery

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer surgery

CDC on Vaginal cancer surgery

Vaginal cancer surgery in the news

Blogs on Vaginal cancer surgery

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer surgery


The surgical approach for vaginal cancer requires a radical hysterectomy, upper vaginectomy, and bilateral pelvic lymphadenectomy. If a hysterectomy has been performed previously, then radical vaginectomy and bilateral lymphadenectomies should be done to complete the surgical therapy. Patients with stage I vaginal cancer appear to have the best outcomes when treated surgically. Early-stage disease had a mean five-year survival rate of 77 percent, which was far better than those with later-stage disease, regardless of whether or not adjuvant RT was administered.

Surgical therapy


  1. Ireland D, Monaghan JM (October 1988). "The management of the patient with abnormal vaginal cytology following hysterectomy". Br J Obstet Gynaecol. 95 (10): 973–5. PMID 3191050.
  2. Stock RG, Chen AS, Seski J (January 1995). "A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities". Gynecol. Oncol. 56 (1): 45–52. doi:10.1006/gyno.1995.1008. PMID 7821847.
  3. Hacker NF, Eifel PJ, van der Velden J (October 2012). "Cancer of the vagina". Int J Gynaecol Obstet. 119 Suppl 2: S97–9. doi:10.1016/S0020-7292(12)60022-8. PMID 22999510.
  4. Shah CA, Goff BA, Lowe K, Peters WA, Li CI (May 2009). "Factors affecting risk of mortality in women with vaginal cancer". Obstet Gynecol. 113 (5): 1038–45. doi:10.1097/AOG.0b013e31819fe844. PMC 2746762. PMID 19384118.
  5. Sillman FH, Fruchter RG, Chen YS, Camilien L, Sedlis A, McTigue E (January 1997). "Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management". Am. J. Obstet. Gynecol. 176 (1 Pt 1): 93–9. PMID 9024096.
  6. Tjalma WA, Monaghan JM, de Barros Lopes A, Naik R, Nordin AJ, Weyler JJ (June 2001). "The role of surgery in invasive squamous carcinoma of the vagina". Gynecol. Oncol. 81 (3): 360–5. doi:10.1006/gyno.2001.6171. PMID 11371123.